Natco Pharma Q1 profit rises 68% to Rs47 crore
Natco Pharma's profit, just short of analysts' estimates, was driven by sales growth of its domestic formulations business09-08-2016
09-08-2016
Fixes Record Date for Interim Dividend
Natco Pharma Ltd has informed BSE that the Company has fixed August 22, 2016 as the Record Date for the purpose of Payment of Interim Dividend.The said interim dividend pay-by-date is August 31, 2016.09-08-2016
Outcome of Board Meeting
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 09, 2016, inter alia, approved the following items and recommended to the members for their approval in the ensuing Annual General Meeting:1. Granting of 1,75,000 Employee Stock options (NATSOP2016) to the eligible employees of the Company.2. Increase of remuneration to Working Directors.09-08-2016
Board declares Interim Dividend (AGM on Sept 30, 2016)
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 09, 2016, inter alia, have transacted the following:1. Recommended payment of an interim dividend of Rs. 0.75 ps. on each equity share of Rs. 2/- each for the year 2016-17.2. The date of Annual General Meeting is on September 30, 2016 and Board had authorised Mr. V. C. Nannapaneni, Chairman and Managing Director for finalizing...09-08-2016
Announces Q1 (Standalone & Consolidated) results, Limited Review Report (Standalone & Consolidated) & Results Press Release for the Quarter ended June 30, 2016
Natco Pharma Ltd has announced the following results for the quarter ended June 30, 2016:"The Unaudited Standalone results for the Quarter ended June 30, 2016The Company has posted a net profit of Rs. 508.70 million for the quarter ended June 30, 2016 where as the same was at Rs. 339.10 million for the quarter ended June 30, 2015. Total Income is Rs. 3143.50 million for the quarter ended June 30, 2016 where as the same was at Rs....09-08-2016
Natco Pharma hits 52-week high on USFDA nod for generic Tamiflu
The stock rallied 7% to Rs 650 also its 52-week high on the National Stock Exchange in early morning trade.04-08-2016
Natco receives final approval for Generic Tamiflu
Natco Pharma Ltd has informed BSE regarding a Press Release dated August 04, 2016 titled "Natco receives final approval for Generic Tamiflu".04-08-2016
Intimation regarding Conference Call
Natco Pharma Ltd has informed BSE regarding "Intimation regarding Conference Call".02-08-2016
Q1 Results on Aug 09, 2016
Natco Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on August 09, 2016, inter alia, to consider the following items of businesses and related matters:1. Unaudited financial Results for the quarter ended June 30, 2016.2. To Consider Interim Dividend, if any, for the year 2016-17....30-07-2016
Buy Natco Pharma Ltd., target Rs 655.0 : Pritesh Mehta
Buy Natco Pharma Ltd. at a price target of Rs 655.0 and a stop loss at Rs 600.0 from entry point28-07-2016